Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:20 pm Sale | 2022-12-31 | 13G | Kezar Life Sciences, Inc. KZR | BB BIOTECH AG | 300,000 4.400% | -191,815 (-39.00%) | Filing History |
| 2023-02-14 3:44 pm Purchase | 2022-12-31 | 13G | Kezar Life Sciences, Inc. KZR | Avidity Partners Management LP | 678,240 9.900% | 355,420 (+110.10%) | Filing History |
| 2023-02-13 10:27 am Purchase | 2022-12-31 | 13G | Kezar Life Sciences, Inc. KZR | Suvretta Capital Management, LLC | 350,426 5.100% | 36,246 (+11.54%) | Filing History |
| 2023-02-03 4:27 pm Purchase | 2022-12-31 | 13G | Kezar Life Sciences, Inc. KZR | BlackRock Inc. BLK | 423,091 6.200% | 135,967 (+47.35%) | Filing History |
| 2023-02-03 2:53 pm Purchase | 2022-12-31 | 13G | Kezar Life Sciences, Inc. KZR | STATE STREET CORP STT | 425,396 6.220% | 425,396 (New Position) | Filing History |
| 2023-01-31 2:39 pm Sale | 2022-12-31 | 13G | Kezar Life Sciences, Inc. KZR | FRANKLIN RESOURCES INC BEN | 136,532 2.000% | -112,086 (-45.08%) | Filing History |
| 2023-01-17 4:15 pm Sale | 2022-12-31 | 13G | Kezar Life Sciences, Inc. KZR | Millennium Management LLC | 289,650 4.200% | -13,013 (-4.30%) | Filing History |
| 2022-06-23 4:49 pm Purchase | 2022-06-17 | 13G | Kezar Life Sciences, Inc. KZR | Millennium Management LLC | 302,663 5.000% | 302,663 (New Position) | Filing History |
| 2022-06-13 4:32 pm Purchase | 2022-06-03 | 13G | Kezar Life Sciences, Inc. KZR | Suvretta Capital Management, LLC | 314,180 5.200% | 314,180 (New Position) | Filing History |
| 2022-05-09 3:23 pm Purchase | 2022-04-30 | 13G | Kezar Life Sciences, Inc. KZR | BlackRock Inc. BLK | 287,124 4.800% | 18,422 (+6.86%) | Filing History |
| 2022-02-14 3:00 pm Sale | 2021-12-31 | 13G | Kezar Life Sciences, Inc. KZR | Logos Global Management LP | 145,000 3.000% | -105,000 (-42.00%) | Filing History |
| 2022-02-11 4:41 pm Purchase | 2021-12-31 | 13G | Kezar Life Sciences, Inc. KZR | BB BIOTECH AG | 491,815 9.200% | 38,500 (+8.49%) | Filing History |
| 2022-02-04 2:36 pm Purchase | 2021-12-31 | 13G | Kezar Life Sciences, Inc. KZR | FRANKLIN RESOURCES INC BEN | 248,619 5.100% | 248,619 (New Position) | Filing History |
| 2022-02-03 4:41 pm Purchase | 2021-12-31 | 13G | Kezar Life Sciences, Inc. KZR | BlackRock Inc. BLK | 268,702 5.500% | 16,793 (+6.67%) | Filing History |
| 2022-01-03 12:09 pm Purchase | 2021-12-30 | 13G | Kezar Life Sciences, Inc. KZR | Avidity Partners Management LP | 322,820 6.600% | 322,820 (New Position) | Filing History |
| 2021-07-28 6:52 pm Purchase | 2021-07-19 | 13G | Kezar Life Sciences, Inc. KZR | Logos Global Management LP | 250,000 5.200% | 250,000 (New Position) | Filing History |
| 2021-02-16 4:15 pm Unchanged | 2020-12-31 | 13D | Kezar Life Sciences, Inc. KZR | Morningside Venture Investments Limited | 625,455 13.500% | 0 (Unchanged) | Filing History |
| 2021-02-12 4:52 pm Purchase | 2020-12-31 | 13G | Kezar Life Sciences, Inc. KZR | BB BIOTECH AG | 453,315 9.800% | 298,248 (+192.33%) | Filing History |
| 2021-02-12 4:15 pm Sale | 2020-12-31 | 13G | Kezar Life Sciences, Inc. KZR | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -203,979 (Position Closed) | Filing History |
| 2021-02-08 10:25 am Sale | 2021-02-05 | 13G | Kezar Life Sciences, Inc. KZR | FMR LLC | 186,573 4.032% | -56,457 (-23.23%) | Filing History |